Literature DB >> 2013157

Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes.

S L Woodley1, M McMillan, J Shelby, D H Lynch, L K Roberts, R D Ensley, W H Barry.   

Abstract

BACKGROUND: The mechanisms by which ventricular function is altered during cardiac transplant rejection are not well understood. Therefore, an in vitro model system has been developed to facilitate investigation of lymphocyte-mediated myocyte injury. METHODS AND
RESULTS: Splenic lymphoid cells were obtained from mice 8-10 days after placement of a vascularized abdominal cardiac allograft and were restimulated in vitro with irradiated donor-type splenocytes for 5 days. Cytotoxic effects of these allogenically stimulated lymphocytes on syngeneic and donor strain fetal cultured myocytes were determined by a 51Cr release assay at different lymphocyte to myocyte ratios. 51Cr release from donor strain myocytes was detectable within 1 hour of exposure, was maximal by 3-5 hours of coincubation with sensitized lymphocytes, and was allospecific. Cell injury manifest by 51Cr release was calcium dependent and was inhibited by pretreatment of lymphocytes with phorbol ester to deplete protein kinase C. Myocyte injury was also prevented by pretreatment of sensitized lymphocytes with anti-Thy 1.2 or anti-CD8 antibody plus complement but not by treatment with anti-CD4 antibody, indicating that CD8+ cytotoxic T cells are involved. Altered myocyte contractile motion preceded myocyte lysis (51Cr release), was characterized by an initial reversible decrease in amplitude of contraction, and was followed by rapid and irregular beating with eventual complete cessation of contraction. Contractile alterations induced by sensitized lymphocytes were inhibited by elimination of CD8+ cells.
CONCLUSIONS: Myocyte injury can be produced by sensitized cytotoxic T lymphocytes in vitro and is calcium and protein kinase C dependent. The contractile abnormalities produced appear to be similar to those observed in cardiac transplant patients undergoing rejection, and thus this model system promises to allow investigation of the mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013157     DOI: 10.1161/01.cir.83.4.1410

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  Cellular and molecular basis of inflammatory myocardial disease.

Authors:  W H Barry
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 2.  Mechanisms in acute septic cardiomyopathy: evidence from isolated myocytes.

Authors:  K Werdan; U Müller; C Reithmann; A Pfeifer; S Hallström; B Koidl; G Schlag
Journal:  Basic Res Cardiol       Date:  1991 Sep-Oct       Impact factor: 17.165

3.  A predicted secondary structural domain within the internal ribosome entry site of echovirus 12 mediates a cell-type-specific block to viral replication.

Authors:  S S Bradrick; E A Lieben; B M Carden; J R Romero
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Mechanisms whereby cytotoxic T lymphocytes damage guinea-pig ventricular myocytes in vitro.

Authors:  B Felzen; G Berke; D Rosen; O Binah
Journal:  Pflugers Arch       Date:  1994-07       Impact factor: 3.657

5.  CD8+ T-cells negatively regulate inflammation post-myocardial infarction.

Authors:  Daria V Ilatovskaya; Cooper Pitts; Joshua Clayton; Mark Domondon; Miguel Troncoso; Sarah Pippin; Kristine Y DeLeon-Pennell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-19       Impact factor: 4.733

Review 6.  Therapeutic potential of protein kinase C inhibitors.

Authors:  D Bradshaw; C H Hill; J S Nixon; S E Wilkinson
Journal:  Agents Actions       Date:  1993-01

7.  Experimental rat model representing both acute and chronic heart failure related to autoimmune myocarditis.

Authors:  S Koyama; M Kodama; T Izumi; A Shibata
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

8.  The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.

Authors:  Z Tu; N M Chapman; G Hufnagel; S Tracy; J R Romero; W H Barry; L Zhao; K Currey; B Shapiro
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment.

Authors:  W C Aird; J M Edelberg; H Weiler-Guettler; W W Simmons; T W Smith; R D Rosenberg
Journal:  J Cell Biol       Date:  1997-09-08       Impact factor: 10.539

Review 10.  Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors.

Authors:  F van den Akker; S C A de Jager; J P G Sluijter
Journal:  Mediators Inflamm       Date:  2013-12-10       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.